MCC-134, a novel vascular relaxing agent, is an inverse agonist for the pancreatic-type ATP-sensitive K+ channel

Journal of Pharmacology and Experimental Therapeutics

Volumn 292, Issue 1, 2000, Pages 131-135

  Shindo, Takashi ^a   Katayama, Yusuke ^a   Horio, Yoshiyuki ^a   Kurachi, Yoshihisa ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 [4 (1H IMIDAZOL 1 YL)BENZOYL] N METHYLCYCLOBUTANECARBOTHIOAMIDE; DIAZOXIDE; POTASSIUM CHANNEL; SODIUM CYANIDE; SULFONYLUREA RECEPTOR; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ARTICLE; CHANNEL GATING; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; ELECTROPHYSIOLOGY; EMBRYO; HUMAN; HUMAN CELL; KIDNEY CELL; PANCREAS ISLET BETA CELL; POTASSIUM CURRENT; PRIORITY JOURNAL; VASODILATATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CELLS, CULTURED; CLONING, ORGANISM; DIAZOXIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMIDAZOLES; KIDNEY; MEMBRANE POTENTIALS; MICE; PANCREAS; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RATS; RECEPTORS, DRUG; SODIUM CYANIDE; THIOAMIDES; VASODILATOR AGENTS;

EID: 0033985526     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Aguilar-Bryan L, Nichols CG, Wechsler SW, Clement JP IV, Boyd AE III, González G, Herrera-Sosa H, Nguy K, Bryan J and Nelson DA (1995) Cloning of the β cell high-affinity sulfonylurea receptor: A regulator of insulin secretion. Science (Wash DC) 268:423-426.
2. Ashcroft FM (1988) Adenosine 5′-triphosphate-sensitive potassium channels. Annu Rev Neurosci 11:97-118.
3. Beech DJ, Zhang H, Nakao K and Bolton TB (1993) K channel activation by nucleotide diphosphates and its inhibition by glibenclamide in vascular smooth muscle cells. Br J Pharmacol 110:573-582.
4. Cleveland JC, Meldrum DR, Cain BS, Banerjee A and Harken AH (1997) Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Circulation 96:29-32.
5. Dawson RMC, Elliot DC, Elliot WH and Jones KM (1986) Stability constants of metal complexes, in Data for Biochemical Research, 3rd ed., Oxford University Press, New York.
6. Duchen MR ( 1990) Effects of metabolic inhibition on the membrane properties of isolated mouse primary sensory neurones. J Physiol 424:387-409.
7. Faivre JF and Findlay I (1989) Effects of tolbutamide, glibenclamide and diazoxide upon action potentials recorded from rat ventricular muscle. Biochim Biophys Acta 984: 1-5.
8. Garratt KN, Brady PA, Hassinger NL, Grill DE, Terzic A and Holmes DR Jr (1999) Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol 33: 119-124.
9. 2+ and ATP dependence of KATP channel modulator binding to the recombinant sulphonylurea receptor, SUR2B. Br J Pharmacol 125:577-583.
10. KATP: An inward rectifier subunit plus the sulfonylurea receptor. Science (Wash DC) 270:1166-1170.
11. + channels. Neuron 16:1011-1017.
12. + channel. J Biol Chem 271:24321-24324.
13. Milligan G, Bond RA and Lee M (1995) Inverse agonism: Pharmacological curiosity or potential therapeutic strategy? Trends Pharmacol Sci 16:10-13.
14. Ohta Y, Tanizawa Y, Inoue H, Hosaka T, Ueda K, Matsutani A, Repunte VP, Yamada M, Kurachi Y, Bryan J, Aguilar-Bryan L, Permutt MA and Oka Y (1998) Identification and functional analysis of sulfonylurea receptor 1 variants in Japanese patients with NIDDM. Diabetes 47:476-481.
15. + channel expressed in a mammalian cell line, HEK293T cells. Pfluegers Arch 435:595-603.
16. Quayle JM, Nelson MT and Standen NB (1997) ATP-sensitive and inwardly recti-fying potassium channels in smooth muscle. Physiol Rev 77:1165-1232.
17. Sakura H, Ämmälä C, Smith PA, Gribble FM and Aschcroft FM (1995) Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic β-cells, brain, heart and skeletal muscle. FEBS Lett 377:338-344.
18. Satoh E, Yamada M, Kondo C, Okuyama Y, Repunte VP, Horio Y, lijima T and Kurachi Y (1998) Intracellular nucleotide-mediated gating of SUR/Kir6.0 complex potassium channels expressed in a mammalian cell line and its modification by pinacidil. J Physiol 611:663-674.
19. Schwanstecher M, Sieverding C, Dörschner H, Gross I, Aguilar-Bryan L, Schwanstecher C and Bryan J (1998) Potassium channel openers require ATP to bind and act through sulfonylurea receptors. EMBO J 17:5529-5535.
20. Seino A, Bessho H, Ishibashi A, Nagano T, Shinpuku T, Tsutsui M, Okushima H and Narimatsu A (1996) Characterization of vasorelaxant action of MCC-134, a novel benzenepropanethioamide derivative. Jpn J Pharmacol 71 (Suppl I):141p.
21. + channels by pinacidil and nicorandil. Br J Pharmacol 124:985-991.
22. 2-complexes. Eur J Biochem 165:65-72.
23. + channel-opening drugs. Am J Physiol 269:C525-C545.
24. Tucker SJ, Gribble FM, Zhao C, Trapp S and Ashcroft FM (1997) Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor. Nature (Lond) 387:179-183.
25. + channel. J Physiol 499:715-720.